4.8 Article

Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer

Journal

CANCER RESEARCH
Volume 81, Issue 12, Pages 3162-3173

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-20-3196

Keywords

-

Categories

Funding

  1. NIH, NCI [U01CA76293, U01CA243483, P50CA125123, P30CA22453, R03CA77118, R01CA80127, R01CA84354]
  2. National Institutes of Health, National Institute of Environmental Health Sciences [P30ES006096]
  3. Department of Health and Human Services [HHSN26820100007C, HHSN268201700012C, HHSN75N92020C00001]
  4. CPRIT [RR170048]
  5. Intramural Research Program of the National Human Genome Research Institute, NIH
  6. Mayo Foundation Fund
  7. Free to Breathe
  8. Common Fund of the Office of the Director of the NIH
  9. NCI
  10. National Heart, Lung, and Blood Institute
  11. National Institute on Drug Abuse
  12. National Institute of Mental Health
  13. National Institute of Neurological Disorders and Stroke
  14. National Human Genome Research Institute

Ask authors/readers for more resources

This study identified four genes associated with lung cancer risk, providing guidance for future lung cancer prevention and treatment approaches.
Although lung cancer is known to be caused by environmental factors, it has also been shown to have genetic components, and the genetic etiology of lung cancer remains understudied. We previously identified a lung cancer risk locus on 6q23-25 using microsatellite data in families with a history of lung cancer. To further elucidate that signal, we performed targeted sequencing on nine of our most strongly linked families. Two-point linkage analysis of the sequencing data revealed that the signal was heterogeneous and that different families likely had different risk variants. Three specific haplotypes were shared by some of the families: 6q25.3-26 in families 42 and 44, 6q25.2-25.3 in families 47 and 59, and 6q24.2-25.1 in families 30, 33, and 35. Region-based logarithm of the odds scores and expression data identified the likely candidate genes for each haplotype overlap: ARID1B at 6q25.3, MAP3K4 at 6q26, and UTRN (6q24.1) and PHACTR2 (6q24.2). Further annotation was used to zero in on potential risk variants in those genes. All four genes are good candidate genes for lung cancer risk, having been linked to either lung cancer specifically or other cancers. However, this is the first time any of these genes has been implicated in germline risk. Functional analysis of these four genes is planned for future work. Significance: This study identifies four genes associated with lung cancer risk, which could help guide future lung cancer prevention and treatment approaches.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available